Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
How Do Clinicians Overcome Telemedicine Prescribing Challenges?
Tech & Innovation How Do Clinicians Overcome Telemedicine Prescribing Challenges?

Telemedicine has revolutionized healthcare delivery, enabling clinicians to prescribe medications remotely. This paradigm shift, while enhancing patient access to care, also introduces distinct challenges that providers must navigate to ensure effective treatment. Successful long-term telemedicine

Can Stem Cell Therapy Transform Parkinson's Disease Treatment?
Research & Development Can Stem Cell Therapy Transform Parkinson's Disease Treatment?

Parkinson's disease, a progressive and degenerative brain condition, affects more than 1 percent of individuals over the age of 60 worldwide, leading to symptoms such as slow movements, muscle tremors, stiffness, and difficulty walking. Traditional treatments focus primarily on managing

Why Are Hedge Funds Investing Big in AI and MedTech Healthcare?
Management & Regulatory Why Are Hedge Funds Investing Big in AI and MedTech Healthcare?

The fourth quarter of 2024 witnessed a significant surge in hedge fund investments focused on the healthcare sector, particularly emphasizing advancements in artificial intelligence (AI), biotechnology, and medical technology (MedTech). This pivotal period showcased growing confidence among

New Standard Boosts Genomic Research, Speeds Medical Discoveries
Tech & Innovation New Standard Boosts Genomic Research, Speeds Medical Discoveries

Ivan Kairatov is a Biopharma expert with a deep knowledge of technology and innovation in the industry and extensive experience in research and development. In this interview, we delve into the topic of refget Sequence Collections, a new tool developed to increase the efficiency of genomic

How Are Innovations in Medicine and Nanotech Changing Lives?
Tech & Innovation How Are Innovations in Medicine and Nanotech Changing Lives?

Ivan Kairatov is a distinguished figure in the biopharma industry, renowned for his expertise in tech and innovation within the field. With a robust background in research and development, Ivan has substantially influenced advancements in cellular therapies and drug development. Today, we delve

FDA Grants Fast Track to Verve's VERVE-102 for Heart Disease
Research & Development FDA Grants Fast Track to Verve's VERVE-102 for Heart Disease

Verve Therapeutics has announced a significant advancement in genetic medicine as their investigational drug VERVE-102 receives Fast Track designation from the U.S. Food and Drug Administration (FDA). This approval marks a crucial step in the development of treatments for hyperlipidemia and

Expanding Access to Affordable Hearing Aids Through Telehealth
Tech & Innovation Expanding Access to Affordable Hearing Aids Through Telehealth

Addressing the pervasive issue of hearing loss in America, a new partnership between Health-E Commerce and Jabra Enhance aims to significantly improve access to affordable, high-quality hearing aids. This collaboration capitalizes on the benefits of telehealth and flexible spending accounts (FSAs)

Will Mehmet Oz Revolutionize Telehealth with New CMS Policies?
Management & Regulatory Will Mehmet Oz Revolutionize Telehealth with New CMS Policies?

The rapid advancements in telehealth have been met with a mixture of enthusiasm and concern, especially as regulatory frameworks struggle to keep pace with technological innovations. At the center of this challenge is Mehmet Oz, the newly appointed Administrator of the Centers for Medicare

Human Hypothalamus Study Reveals Cellular and Evolutionary Insights
Tech & Innovation Human Hypothalamus Study Reveals Cellular and Evolutionary Insights

Imagine understanding a part of the brain so intricate and vital that it controls many aspects of human life, from hormone regulation to emotional responses. This quest has driven researchers to the hypothalamus, a small yet essential region of the brain that continuously intrigues scientists due

Imipridones and Standard Treatment Show Promise for Glioblastoma
Research & Development Imipridones and Standard Treatment Show Promise for Glioblastoma

Glioblastoma, one of the most aggressive and treatment-resistant forms of brain cancer, presents a dire prognosis even with current standard treatment regimens including surgery, radiation, and the chemotherapy drug temozolomide (TMZ). However, a groundbreaking study published in Volume 16 of

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later